跳至主要内容
临床试验/EUCTR2012-000454-58-BE
EUCTR2012-000454-58-BE进行中(未招募)不适用

Prospective, monocentre phase I study of sequential infusion of Y90-labeled microspheres and Mitomycine C in patients with chemorefractory liver metastases from breast carcinoma

niversity Hospitals Leuven0 个研究点开始时间: 2012年3月22日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Histologically confirmed diagnosis of breast cancer
  • Radiological evidence of liver metastases
  • Liver-only or liver predominant disease
  • Progressive under (multi-line) systemic chemotherapy
  • Progressive under hormonotherapy for hor+ patients.
  • Patients scheduled for mitomycine chemoinfusion
  • Liver/lung shunt < 20% as determined by the Tc99-scan
  • Age older than 18 years
  • Karnovski >=70
  • Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 5

排除标准

  • . Karnovsky < 70
  • . Biochemical evidence of severe haematological toxicity and liver function test disturbances (Bilirubine > 1.5; AST/ALT > 2.5 fold normal range; Creatinine > 1.2 upper normal limit; GFR (glomerular filtration rate) < 60)
  • . Neutrophiles < 1000/ml
  • . Thrombocytes < 100.000
  • . Liver/lung shunt > 20% as determined by the Tc99-scan
  • . Allergy to contrast media
  • . Intake of oral anticoagulation

研究者

发起方
niversity Hospitals Leuven

相似试验

进行中(未招募)
1 期
Sequential treatment with Gemcitabine/Nab-Paclitaxel then Folfirinox followed by MRI-guided radiotherapy in patients with locally advanced adenocarcinoma of the pancreas
EUCTR2020-002517-18-FRInstitut régional du cancer de Montpellier (ICM)103
进行中(未招募)
1 期
Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
CTIS2024-515344-23-00Institut Regional Du Cancer De Montpellier103
已完成
不适用
Phase II Randomized Comparative Study of Sequential Alternating Therapy with Interferon and Molecular-Targeted Drug for Advanced Renal Cell CarcinomaAdvanced Renal Cell Carcinoma
JPRN-UMIN000001994Osaka Urological Oncology Research Group100
进行中(未招募)
不适用
A study in patients with Tcell lymphoma to look at the effects of a new treatmentPatients with previously undiagnosed peripheral T-cell lymphoma who have achieved an objective response following initial treatment with CHOP based chemotherapyMedDRA version: 14.1Level: PTClassification code 10034623Term: Peripheral T-cell lymphoma unspecifiedSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2010-022230-81-ITALLOS549
已完成
不适用
Correlative observational study of phase 1 study of RK-163 pulsed human autologous CD14-positive cells (RK-CD14MO) for patients with advanced or relapsed solid tumorAdvanced or relapsed solid tumor
JPRN-UMIN000032306Keio University Hospital18